QR-Code

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Abstract Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheumatologists who have initiated secukinumab for the treatment of patie...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Prashanth Sunkureddi, Dominick Latremouille-Viau, Mark K. Meiselbach, Jipan Xie, Peter Hur, Reeti Joshi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Adis, Springer Healthcare 2019-01-01
Schriftenreihe:Rheumatology and Therapy
Schlagworte:
Biologicals
Epidemiology
Psoriatic arthritis
Spondylarthropathies
Online-Zugang:http://link.springer.com/article/10.1007/s40744-018-0137-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge